Using Fluorescent Proteins to Monitor Glycosome Dynamics in the African Trypanosome

Summary

Glycosome dynamics in African trypanosomes are difficult to study by traditional cell biology techniques such as electron and fluorescence microscopy. As a means of observing dynamic organelle behavior, a fluorescent-organelle reporter system has been used in conjunction with flow cytometry to monitor real-time glycosome dynamics in live parasites.

Abstract

Trypanosoma brucei is a kinetoplastid parasite that causes human African trypanosomiasis (HAT), or sleeping sickness, and a wasting disease, nagana, in cattle¹. The parasite alternates between the bloodstream of the mammalian host and the tsetse fly vector. The composition of many cellular organelles changes in response to these different extracellular conditions^2-5.

Glycosomes are highly specialized peroxisomes in which many of the enzymes involved in glycolysis are compartmentalized. Glycosome composition changes in a developmental and environmentally regulated manner^4-11. Currently, the most common techniques used to study glycosome dynamics are electron and fluorescence microscopy; techniques that are expensive, time and labor intensive, and not easily adapted to high throughput analyses.

To overcome these limitations, a fluorescent-glycosome reporter system in which enhanced yellow fluorescent protein (eYFP) is fused to a peroxisome targeting sequence (PTS2), which directs the fusion protein to glycosomes¹², has been established. Upon import of the PTS2eYFP fusion protein, glycosomes become fluorescent. Organelle degradation and recycling results in the loss of fluorescence that can be measured by flow cytometry. Large numbers of cells (5,000 cells/sec) can be analyzed in real-time without extensive sample preparation such as fixation and mounting. This method offers a rapid way of detecting changes in organelle composition in response to fluctuating environmental conditions.

Introduction

Trypanosoma brucei causes African sleeping sickness in humans and a wasting disease, nagana, in cattle. Drugs used in the treatment of these diseases are antiquated and extremely toxic, vaccines are not available, and the potential for the development of drug resistance necessitates the search for new drug targets¹.

During its lifecycle, T. brucei, alternates between an insect vector and mammalian host; two hosts that present very different environments in which the parasite must survive. A number of metabolic and morphological changes occur as the parasite is exposed to different environmental conditions. Some of the most dramatic changes are observed in single-membrane-bounded parasite specific microbodies, termed glycosomes¹³.

Glucose levels are relatively high (~5 mM) in the bloodstream and bloodstream parasites (BSF) generate ATP exclusively through glycolysis while mitochondrial metabolism is repressed¹⁴. Unlike other eukaryotes in which glycolysis occurs in the cytoplasm, T. brucei compartmentalizes most of the glycolytic enzymes in glycosomes^14,15. The parasites are taken up by the tsetse fly during a bloodmeal and experience a drop in glucose, which falls to undetectable levels within 15 min of being ingested by the fly. The metabolism of insect, procyclic form (PCF), parasites is more flexible and glucose, as well as amino acids such as proline, can be used in the synthesis of ATP^16-18. Comparative proteomic studies reveal lifecycle dependent changes in glycosomal and mitochondrial proteins with glycolytic proteins increased in bloodstream parasites and mitochondrial proteins involved in TCA cycle and respiratory chain^13,19. While many studies have focused on the differences between BSF and PCF glycosomes, little is known about the changes in PCF glycosomes that occur in response to environmental changes.

In the hindgut of the fly, glucose levels are low with transient increases during a feeding²⁰. In most in vitro studies, PCF parasites are grown in media containing glucose. However, recent studies have demonstrated that PCF metabolism changes significantly in response to glucose availability¹⁷. In the absence of glucose, proline uptake and proline dehydrogenase activity increase¹⁸. This change in mitochondrial metabolism is likely accompanied by a change in glycosome composition and morphology, however, this has not been directly assessed.

Electron and fluorescence microscopy are common techniques used to study glycosome dynamics in T. brucei^2,21-24. These protocols are time and labor intensive, expensive, and difficult to adapt to real-time studies and high throughput protocols. To overcome this limitation, a fluorescent-organelle reporter system used to study organelles in mammalian and yeast systems has been modified for use in T. brucei¹².

Fluorescent-organelle reporter systems have been extensively used in higher eukaryotes such as yeast, plant, and mammalian cells^25-27. In such systems, a fluorescent protein is fused to an amino acid sequence that targets the protein to specific organelles. The degradation or synthesis of the targeted proteins is measured via fluorescence and changes in organelle composition are reflected by changes in cell fluorescence.

When the open reading frame of enhanced yellow fluorescent protein (eYFP) is fused to a type II peroxisomal targeting sequence (PTS2)¹², the PTS2eYFP protein is imported into mature, import-competent glycosomes and fluorescence can be monitored via flow cytometry. Variations in glycosome composition are reflected by changes in cellular fluorescence. This system can aid in resolving the mechanisms that regulate environmentally induced changes in glycosome composition.

This manuscript describes the generation of a glycosome reporter system in PCF parasites in conjunction with flow cytometry to monitor real-time glycosome dynamics in live parasites and provides an example of how it has been used to follow changes in glycosome composition in response to different environments. In summary, glycosome composition is influenced by extracellular glucose concentrations and passage of log-phase cultures into fresh media triggers changes in glycosome composition. This system can be modified to study the dynamic behavior of other organelles in trypanosomes and other parasites.

Protocol

1. General Trypanosome Husbandry

1. Weigh solids for SDM79 media preparation (Table 1).
2. Store at 4 °C in 50 ml conical or a Ziploc bag. NOTE: Reagents are stable for at least 6 months.
3. Thaw fetal bovine serum (FBS) in a 37 °C waterbath, and mix periodically by inversion. NOTE: FBS is received from the supplier as a sterile solution. Filter sterilizing FBS reduces its ability to support parasite growth.
4. Once the entire bottle is thawed, heat inactivate serum for 30 min in a 56 °C waterbath, mixing periodically to minimize precipitation of serum components.
5. Thaw penicillin/streptomycin solution (pen/strep), hemin (2 mg/ml in 50 mM NaOH), and basal medium eagle vitamin solution at room temperature.
6. To a 1,000 ml graduated cylinder, add 20.2 g of SDM79 solids (Table 1) to the liquid components (Table 2) and mix well on a stir plate.
7. Adjust pH to 7.35, and bring volume to 850 ml with water.
8. Filter sterilize media by attaching a vacuum hose to the bottom of a filter bottle. Apply vacuum until the solution is filtered.
9. Remove filter top in the biosafety cabinet and add 150 ml of heat inactivated FBS. Remove plastic covering from sterile cap and seal media bottle.
10. Prepare SDM80 media in the same way as SDM79 with the following exceptions; do not add glucose or glucosamine and use MEM without glutamine. In place of 150 ml of heat inactivated FBS, add 135 ml of dialyzed, heat inactivated FBS, and 15 ml of heat inactivated FBS.
11. Culture PCF parasites in 25 cm² flask with 10 ml appropriate medium at 27 °C and 5% CO₂. NOTE: Cells should be counted daily using a hemocytometer or a flow cytometer (see section 6) and cultures should be maintained at densities between 1 x 10⁵ and 5 x 10⁶ cells/ml.

2. Transfection of PCF Parasites with the Fluorescent Reporter Construct

NOTE: To follow glycosome dynamics, a reporter protein containing the peroxisomal targeting sequence (PTS2) of aldolase fused to enhanced yellow fluorescent protein is expressed in the parasites. The sequence encoding the fusion protein is cloned into pXS2bla¹², which contains the procyclin promoter and the tubulin intergenic regions, which direct homologous recombination into the genome and the blasticidin resistance gene for selection. Procyclic cell lines harboring the genes encoding the T7 polymerase and tetracycline repressor (PF29-13) are transformed with the targeting construct, pXS2:PTS2eYFP.

1. Prepare cytomix by mixing the components listed in Table 3. Filter sterilize and store at RT.
2. Linearize plasmid DNA with MluI by pipetting 10 μl of DNA (1 μg/μl), 5 μl restriction enzyme buffer, 33 μl water, and 2 μl of MluI enzyme into a microcentrifuge tube. Incubate at 37 °C for 1 hr.
3. Purify the restriction digest by adding 1 volume of binding buffer to the restriction enzyme digest. Mix binding buffer and digested DNA by vortexing. Briefly centrifuge to collect the sample at the bottom of the tube.
4. Insert a DNA binding column into a 2 ml collection tube, and transfer digested DNA/binding buffer solution to column.
5. Centrifuge for 10,000 x g for 1 min. After centrifugation, discard filtrate from collection tube and return the column to the collection tube.
6. Add 700 µl of SPW wash buffer and centrifuge at 10,000 x g for 1 min.
7. Discard filtrate from collection tube, return the column to the collection tube and repeat SPW wash step and centrifugation.
8. Discard filtrate, return column to collection tube, and centrifuge empty column for 3 min at 10,000 x g to remove residual ethanol.
9. In a biosafety cabinet, throw away collection tube and place column in a sterile microcentrifuge tube.
10. To elute the DNA, add 25 µl of sterile water to column and incubate at room temperature for 2 min. Centrifuge at 10,000 x g for 1 min.
11. Add another 25 µl of sterile water in biosafety hood to column and incubate at room temperature for 2 min.
12. Centrifuge at 10,000 x g speed for 1 min.
13. In a biosafety cabinet transfer entire volume of DNA to a new sterile microcentrifuge tube. NOTE: This step prevents contamination from the open lid during centrifugation.
14. Add the sterile, purified, linearized DNA (10 µg) to 400 µl of filter-sterilized cytomix.
15. Count cells as described in section 6 and harvest 5 x10⁷-10⁸ cells by centrifugation at 800 x g for 15 min at RT.
16. Pour off supernatant and resuspend the cell pellet in 450 µl of DNA + cytomix using a 1 ml serological pipette.
17. Transfer solution containing cells, DNA, and cytomix to a sterile 4 mm gap cuvette and place cuvette in the electroporation chamber.
18. Select “Exponential decay” and manually enter the following settings: Voltage: 1.5 kV, Capacitance: 25 mF, Resistance: Ω, and Cuvette: 4 mm. Press pulse. Once the pulse is complete, remove cuvette from the electroporation chamber and return to the biosafety cabinet.
19. Into a new sterile flask, pipette 10 ml of SDM79. Transfer the transformed cells to the flask with 10 ml of SDM79.
20. Incubate WITHOUT drug selection for 24 hr at 27 °C, 5% CO₂. After 24 hr, add G418 (15 µg/ml), hygromycin (50 µg/ml), and blasticidin (10 µg/ml). Pass 1 ml of transformed cells with drug into 9 ml of SDM79 with drug.
21. Analyze cells daily as described in sections 6 and 7. When cells are fluorescent, and have reached a cell density of 1 x 10⁷/ml, make stabilates for long-term storage (3.1-3.3).

3. Making Stabilates

1. To make freezing media, add an equal volume of 100% glycerol to cytomix and filter sterilize.
2. Add 200 µl of freezing media to 800 µl of cells (1 x 10⁷) in a cryovial, mix gently by inversion and place between two Styrofoam racks and freeze at -80 °C.
3. Once frozen (~24 hr), transfer cells to liquid nitrogen. NOTE: It is important to move cells into LN₂ after 24 hr, as longer storage at -80 °C leads to a decrease in cell viability.

4. Thawing Frozen Stocks

1. Remove frozen vial from -80 °C and thaw at RT for approximately 10 min.
2. Pipette 9 ml of SDM79 with drug into a new sterile flask. Add thawed cells to this flask. Pass cells 1:10 by adding 1 ml of this culture to 9 ml of SDM79 in a new flask (final concentration of 1 x 10⁵/ml).
3. Before the cells reach a density of 10⁷/ml, begin cytometer setup and dilution assays.

5. Cytometer Setup

1. Turn on the flow cytometer and open CFlow Plus program. NOTE: Before running any samples, the fluidics should be backflushed and rinsed according to steps 5.2-5.7.
2. Replace the tube of nanopure water in which the sip is stored with an empty tube.
3. Select the “backflush” button.
4. Once backflush is complete, remove microcentrifuge tube from sip and discard.
5. Place a new microcentrifuge tube containing 1 ml of new nanopure water on the sip.
6. Select a new well in CFlow program. Under “Run Limits” set time for 2 min. Under “Fluidics” select “fast” and “Run”.
7. Once the 2 min time limit is complete, click the “Delete Sample Data” button.

6. Cell Counting using the Flow Cytometer

1. Replace water with the sample to be counted. Set “Run Limits” to 30 sec, “Fluidics” to “fast” and then select “Run”.
2. After the 30 sec time limit is complete, CFlow plus will provide the events/μl under “Last Run.” Repeat count for each culture. NOTE: Before cells reach 1 x 10⁷ cells/ml, proceed with dilution assay. Cells should be discontinued after one dilution assay is completed. Cells cultured for longer periods lose their ability to respond to environmental conditions.

7. Measuring Fluorescence using the Flow Cytometer

1. To assess fluorescence, set “Run Limits” to 10,000 events, and “Fluidics” to “slow”. Select “Set threshold”. Under “Primary Threshold”, select “Permanently eliminate events on”, “FSC-H” (in drop down box) and enter less than 30,000. Click “apply”, then “close”.
2. Select the “Histogram” button in one of the new plot windows and select “FSC-A” From the drop down list, select “FL1-A”. NOTE: FL1-A measures fluorescence in the 530 nm wavelength.
3. Select “Run” and repeat for all cultures.
4. Run cleaning solution through the fluidics line for 2 min and water for 2 min.

8. Dilution Assays

1. Pass cells to a density of 1 x 10⁵ cells/ml in 3 ml of SDM79 in a 25 cm² culture flask and measure florescence immediately after passage and then at 3 hr and 24 hr.

9. Data Analysis

1. Select “Analyze” tab on CFlow Plus.
2. Click “Histogram” button under “Make a new plot.” Select “FSC-A” and a drop down list will appear. Select channel “FL1-A.”
3. Highlight a well to analyze. Select “Gate” button, and manually draw a gate for the population of interest.
4. Flow Plus will provide cell “Count” within this gate and “% of This Plot”.

Results

In this system, a glucose-dependent change in glycosome composition was observed. When cells are grown in glucose containing media, two populations are observed; one bright and one dim (Figure 2A). Dim cells harbor immature glycosomes, which have not imported the PTS2eYFP while bright cells harbor a mixture of mature and immature glycosomes¹². When glucose is present in the media, mislocalization of glycosome proteins is lethal^15,28 and glycosome protein expression is likely coupled...

Discussion

Glycosomes are essential, dynamic, parasite-specific organelles. The processes that regulate the biogenesis, maintenance, proliferation and remodeling of these organelles likely include drug targets that could be exploited for therapeutic purposes. Despite the potentially high abundance of such drug targets, the field of glycosome biogenesis has lagged behind the study of similar processes in other organisms, predominately due to the lack of a tractable, high-throughput system by which to monitor rapid, dynamic, organell...

Materials

Name	Company	Catalog Number	Comments
Adenosine	Avocado Research Chemicals Ltd	A10781	SDM79 Ingredient
L-Alanine	Avocado Research Chemicals Ltd	A15804	SDM79 Ingredient
L-Arginine	CalBiochem	1820	SDM79 Ingredient
p-Aminobenzoic acid	ICN Biomedicals	102569	SDM79 Ingredient
Basal Medium Eagle Vitamin Solution (100x)	Sigma	B6891	SDM79 Ingredient
Biotin	Fisher	BP232-1	SDM79 Ingredient
Calcium chloride	VWR	BDH0224	Cytomix
EDTA	Fisher	S311-100	Cytomix ingredient
EZNA Gel Extraction kit	Omega Biotek	D2500-01	DNA purifiation
Research grade Serum	Fisher	03-600-511	SDM79 Ingredient
Folic acid	ICN Biomedicals	101725	SDM79 Ingredient
Glucosamine HCl	ICN Biomedicals	194671	SDM79 Ingredient
Glucose	GIBCO	15023-021	SDM79 Ingredient
L-Glutamine	CalBiochem	3520	SDM79 Ingredient
Glycerol	Acros Organics	Ac15892-0010	Freezing media
Graces insect cell media powder	GIBCO	11300-043	SDM79 Ingredient
Hemin	MP Biomedicals	194025	SDM79 Ingredient
Guanosine	Avocado Research Chemicals Ltd	A11328	SDM79 Ingredient
HEPES	MP Biomedicals	194025	SDM79 Ingredient
Magnesium chloride	Fisher	BP214-500	Cytomix ingredient
L-Methionine	Fisher	BP388-100	SDM79 Ingredient
MEM Amino Acids (50x)	Cellgro	25-030-CI	SDM79 Ingredient
NEAA Mixture (100x)	Lonza	13-114E	SDM79 Ingredient
Minimal Essential Medium (1x) with L-glutamine	Cellgro	10-010-CM	SDM79 Ingredient
MOPS	Fisher	BP308-500	SDM79 Ingredient
Sodium biocarbonate	Fisher	S233-500	SDM79 Ingredient
Penicillin-streptomycin Solution	Cellgro	30-002-CI	SDM79 Ingredient
L-Phenylalanine	ICN Biomedicals	102623	SDM79 Ingredient
Potassium chloride	Fisher	P217-500	Cytomix ingredient
Potassium phosphate dibasic anhydrous	Fisheer	P290-212	Cytomix ingredient
L-Proline	Fisher	BP392-100	SDM79 Ingredient
L-Serine	Acros Organics	56-45-1	SDM79 Ingredient
Pyruvic acid, sodium salt	Acros Organics	113-24-6	SDM79 Ingredient
L-Taurine	TCI America	A0295	SDM79 Ingredient
L-Threonine	Acros Organics	72-19-5	SDM79 Ingredient
L-Tyrosine	ICN Biomedicals	103183	SDM79 Ingredient
E.Z.N.A. Cycle Pure kit	Omega Biotek	D6492-02	DNA purification
Binding buffer	Omega Biotek	PDR041	DNA purification
SPW wash buffer	Omega Biotek	PDR045	DNA purification
Gene Pulser Xcell	Biorad	165-2660	Trypanosome transformation
4 mm Electroporation cuvettes	VWR		Trypanosome transformation